Rydex Health Care Fund Class A RYHEX

Medalist Rating as of | See Rydex Investment Hub
  • NAV / 1-Day Return 128.26  /  −0.58 %
  • Total Assets 21.4M
  • Adj. Expense Ratio
    1.640%
  • Expense Ratio 1.640%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 236%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:11 AM GMT+0

Morningstar’s Analysis RYHEX

Will RYHEX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Rydex Health Care A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RYHEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 24.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

4.54 836,485
Healthcare

Johnson & Johnson

3.10 570,085
Healthcare

UnitedHealth Group Inc

3.03 557,534
Healthcare

AbbVie Inc

2.66 488,781
Healthcare

Merck & Co Inc

2.39 439,858
Healthcare

Thermo Fisher Scientific Inc

1.93 356,085
Healthcare

Amgen Inc

1.80 331,065
Healthcare

Gilead Sciences Inc

1.72 315,776
Healthcare

Pfizer Inc

1.67 307,746
Healthcare

Intuitive Surgical Inc

1.61 295,549
Healthcare

Sponsor Center